NOMAD Power Solutions, Inc.(NMAD)

Biotechnology · Boca Raton, FL

$4.35+0.33 (+8.22%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T20:52:29.967Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:52:29.967Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 4.345
Unrounded diluted TTM EPS · period ending 2026-06-30: -1

FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

NMAD PE Ratio Metrics

PE RATIO

N/A

NMAD Competitors' PE Ratio

NMAD

NOMAD Power Solutions, Inc.

Current

Market Cap

$53.70M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs NMAD

Market Cap

$54.14M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs NMAD

Market Cap

$52.83M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZYBT

Zhengye Biotechnology Holding Limited

vs NMAD

Market Cap

$52.60M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs NMAD

Market Cap

$55.25M

PE Ratio

N/A

TTM Avg

2.27

3Y Avg

2.27

5Y Avg

2.27

ELOX

Eloxx Pharmaceuticals, Inc.

vs NMAD

Market Cap

$51.99M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs NMAD

Market Cap

$51.88M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKYO

OKYO Pharma Limited

vs NMAD

Market Cap

$56.02M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs NMAD

Market Cap

$51.23M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TENX

Tenax Therapeutics, Inc.

vs NMAD

Market Cap

$51.19M

PE Ratio

N/A

TTM Avg

1.95

3Y Avg

1.95

5Y Avg

1.95

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
NOMAD Power Solutions, Inc. (NMAD)	$53.70M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$54.14M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$52.83M	N/A	N/A	N/A	N/A
Zhengye Biotechnology Holding Limited (ZYBT)vs ›	$52.60M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$55.25M	N/A	2.27	2.27	2.27
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.99M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$51.88M	N/A	N/A	N/A	N/A
OKYO Pharma Limited (OKYO)vs ›	$56.02M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.23M	N/A	N/A	N/A	N/A
Tenax Therapeutics, Inc. (TENX)vs ›	$51.19M	N/A	1.95	1.95	1.95

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

NMAD PE Ratio Metrics

NMAD Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics